Psychedelic experience sources of some psychedelic drugs such as ayahuasca and mescaline-containing cacti are sometimes referred to as "plant teachers". Similarly, in a follow-up to the psilocybin and mysticism study at Johns Hopkins, researchers observed that psilocybin: "occasions personally and spiritually significant mystical experiences that predict long-term changes in behaviors, attitudes and values". Psychedelic experience includes the full range of mystical or religious experiential phenomena. Two scientific studies have concluded that psilocybin (a typical psychedelic compound that occurs naturally in psilocybin mushrooms) reliably triggers mystical-type experiences. The more recent study at Johns Hopkins University identified mystical experiences by means of several questionnaires
Boldenone Boldenone acts similar to metandienone with fewer adverse androgenic effects. Although commonly compared to nandrolone, boldenone lacks progesterone receptor interaction and associated progestogenic side effects. Boldenone, also known as Δ-testosterone, 1-dehydrotestosterone, or androsta-1,4-dien-17β-ol-3-one, is a naturally occurring androstane steroid and a derivative of testosterone. It is specifically testosterone with a double bond between the C1 and C2 positions. A related compound is quinbolone, the 17-cyclopentenyl enol ether of boldenone. Boldenone occurs naturally in the scent gland of "Ilybius fenestratus", a species of aquatic beetle. Ciba reportedly patented boldenone in 1949. It subsequently developed several experimental esters of the drug in